![MCED: A New Screening Paradigm?](https://www.g2intelligence.com/wp-content/uploads/2024/05/June24.CDI_.MCED_Testing.MS-iStock-1481732551_1100x800-1080x675.jpg)
MCED: A New Screening Paradigm?
Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers
Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.